ArticleScientific reports2025
Global, regional, and national epidemiology of osteoarthritis in working-age individuals: insights from the global burden of disease study 1990-2021.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of Bariatric Surgery on Osteoarthritis-Related Pain and Function: A Systematic Review and Meta-Analysis.World journal of surgery · 2026Pooled it
- Unveiling the BMI Risk Threshold for Osteoarthritis: Multi-Database Causal and Nonlinear Evidence.Diabetes, obesity & metabolism · 2026Article
- Six-session non-operative exercise program yields sustained benefits for up to 18 months in end-stage knee osteoarthritis: a retrospective cohort study.Clinical rheumatology · 2026Article
- Development of an injectable thermosensitive hydrogel depot system for controlled and sustained subcutaneous drug delivery.International journal of pharmaceutics: X · 2026Article
- Racial and ethnic variation in the prevalence of knee osteoarthritis among older U.S. adults, including Asian ethnic populations.Osteoarthritis and cartilage open · 2026Article
- Smart Nanodelivery Systems for Immunometabolic Modulation in Osteoarthritis.Exploration (Beijing, China) · 2026Review
- Osteoarthritis and rheumatoid arthritis: A comparative review of pathophysiology, diagnosis and evolving management.Journal of Taibah University Medical Sciences · 2026Review
- Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGEInternational journal of molecular sciences · 2026Article
- Amelioration of Disease Manifestations by Saffron Extract in a Mouse Model of Collagenase-Induced Osteoarthritis.International journal of molecular sciences · 2026Article
- Synergistic modulation of nociceptive and inflammatory pain by palmitoylethanolamide and Cucumis sativus extract in a monosodium-iodoacetate induced osteoarthritic rat model.Inflammopharmacology · 2026Article
- Review
- Beyond Histology: Tensiomyography as an Integrated Measure of Muscle Function in Osteoporotic and Osteoarthritic Patients.Journal of clinical medicine · 2026Article
- Integrative multi-omics identifiesFrontiers in immunology · 2026Article
- Multimodal modulation of metal-based nanomaterials in osteoarthritis immunotherapy: current landscape and future paradigms.Frontiers in immunology · 2026Review
- Epidemiological trends and burden of osteoarthritis in the United States: insights from the GBD 2021 study.Archives of medical science : AMS · 2026Article
- Research progress on the role of CD14 in osteoarthritis.Frontiers in immunology · 2026Review
- Sex hormones and their receptors in osteoarthritis: current research progress.Annals of joint · 2026Review
- Global prevalence, incidence, and years lived with disability (YLDs) of osteoarthritis: trends from 1990 to 2021 and projections to 2050.Journal of orthopaedic translation · 2026Article
- Osteoarthritis in older adults: A global health challenge and the role of high BMI in shaping disease trends.PloS one · 2026Article
- MAPK Pathway Activation Patterns in the Synovium Reveal ERK1/2 and EGFR as Key Players in Osteoarthritis.Biomedicines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Osteoarthritis (OA) is a chronic degenerative joint disease with an increasing global burden, particularly among the working-age population. This study aims to analyze the temporal trends in OA burden by age and sex globally from 1990 to 2021, focusing on incidence, prevalence, and disability-adjusted life years (DALYs) rates, and to predict future trends. Using data from the Global Burden of Disease (GBD) database, which includes 204 countries and regions, we stratified the findings by the sociodemographic index (SDI). Age-standardized rates were used to calculate the estimated annual percentage change (EAPC) with corresponding 95% confidence intervals (95% CI). Additionally, a Bayesian Age-Period-Cohort (BAPC) model was employed to project future OA trends up to 2040.The results revealed a consistent increase in the global OA burden over the study period. Between 1990 and 2021, the number of OA cases in the working-age population increased from 16,420,160 to 35,494,218, representing a growth rate of 116.16%. Over the same period, prevalence and DALYs rose by 123.11% and 125%, respectively. Global age-standardized incidence rate (ASIR), prevalence rate (ASPR), and DALYs rate (ASDR) exhibited continuous upward trends, with annual percentage changes of 0.387%, 0.431%, and 0.46%, respectively. Notably, East Asia demonstrated the highest EAPC, reflecting a rapid rise in OA burden, while high-income North America exhibited minimal changes, indicating a relatively stable trend. Countries such as Equatorial Guinea, Mongolia, and Armenia also experienced significant increases in EAPC, underscoring emerging regional challenges.Further socioeconomic analysis highlighted disparities in OA burden. A significant positive correlation was observed between ASIR, ASPR, ASDR, and SDI. While low-SDI countries exhibited lower OA burdens, metrics were substantially higher in high-SDI countries. From 1990 to 2021, the gap between countries with the highest and lowest SDIs widened, underscoring growing global health inequalities. Projections based on the BAPC model suggest that by 2040, the incidence and prevalence of OA will continue to rise, with the number of cases expected to reach 38,800,395, particularly driven by notable increases among women.These findings highlight the urgent need for developing targeted public health strategies to mitigate the effect of OA on the working-age population and promote global health equity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.